Editorial Comment to Myosteatosis as a novel predictor of urinary incontinence after robot-assisted radical prostatectomy

Affiliations

Editorial

Nobuhiro Haga et al. Int J Urol. 2022 Jan.

. 2022 Jan;29(1):40-41.

doi: 10.1111/iju.14724. Epub 2021 Oct 18.

¹ Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan.

No abstract available

Comment on

Myosteatosis as a novel predictor of urinary incontinence after robot-assisted radical prostatectomy.
Yamashita S, Kawabata H, Deguchi R, Ueda Y, Higuchi M, Muraoka S, Koike H, Kikkawa K, Kohjimoto Y, Hara I. Yamashita S, et al. Int J Urol. 2022 Jan;29(1):34-40. doi: 10.1111/iju.14704. Epub 2021 Sep 17. Int J Urol. 2022. PMID: 34535917

1. Miljkovic I, Vella CA, Allison M. Computed tomography-derived myosteatosis and metabolic disorders. Diabetes Metab. J. 2021; 45: 482-91.
1. Correa-de-Araujo R, Addison O, Miljkovic I et al. Myosteatosis in the context of skeletal muscle function deficit: an interdisciplinary workshop at the National Institute on Aging. Front. Physiol. 2020; 11: 963.
1. Xu MC, Huelster HL, Hatcher JB et al. Obesity is associated with longer survival independent of sarcopenia and myosteatosis in metastatic and/or castrate-resistant prostate cancer. J. Urol. 2021; 205: 800-5.
1. Yamashita S, Kawabata H, Deguchi R et al. Myosteatosis as a novel predictor of urinary incontinence after robot-assisted radical prostatectomy. Int. J. Urol. 2022; 29: 34-40.
1. Haga N, Ogawa S, Yabe M et al. Association between postoperative pelvic anatomic features on magnetic resonance imaging and lower tract urinary symptoms after radical prostatectomy. Urology 2014; 84: 642-9.